Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Amesite Inc (AMST)

Amesite Inc (AMST)
2.14 +0.03 (+1.42%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 2.12 +0.01 (+0.47%) 04/25/25
Cash Flow for Fri, Apr 25th, 2025
Try Excel Barchart for Excel
Watch
    Add or delete the symbol from one or more Watchlists.

Fiscal Year End Date: 06/30

(Values in U.S. thousands)
  06-2024 06-2023 06-2022 06-2021 06-2020
Cash Flows From Operating Activities
Net Income -4,403 -4,153 -9,060 -11,586 -4,170
Depreciation Amortization 534 683 876 934 601
Accounts receivable -15 -1 37 10 -61
Accounts payable and accrued liabilities -21 -52 78 -47 -96
Other Working Capital 221 -30 -122 1 189
Other Operating Activity 871 304 1,477 5,354 727
Operating Cash Flow $-2,814 $-3,249 $-6,716 $-5,335 $-2,810
Cash Flows From Investing Activities
PPE Investments -376 -396 -712 -842 -796
Investing Cash Flow $-376 $-396 $-712 $-842 $-796
Cash Flows From Financing Activities
Debt Issued N/A N/A N/A N/A 1,921
Common Stock Issued N/A 1,851 3,870 12,796 4,770
Financing Cash Flow $N/A $1,851 $3,870 $12,796 $6,691
Beginning Cash Position 5,261 7,055 10,713 4,094 1,009
End Cash Position 2,071 5,261 7,155 10,713 4,094
Net Cash Flow $-3,190 $-1,795 $-3,558 $6,619 $3,085
Free Cash Flow
Operating Cash Flow -2,814 -3,249 -6,716 -5,335 -2,810
Capital Expenditure -376 -396 -712 -842 -796
Free Cash Flow -3,190 -3,645 -7,427 -6,177 -3,606
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective